GSK3β is involved in the relief of mitochondria pausing in a Tau-dependent manner

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Llorens Martín, María ^a   López Doménech, Guillermo ^b,c,d   Soriano, Eduardo ^b,c,d   Avila, Jesús ^a,b  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DYNEIN ADENOSINE TRIPHOSPHATASE; GSK3BETA PROTEIN; KINESIN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN SERINE THREONINE KINASE; TAU PROTEIN; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MITOCHONDRION; MOUSE; NERVE FIBER TRANSPORT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; CELL SURVIVAL; GENETICS; METABOLISM; MOLECULAR IMAGING; NERVE FIBER; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; AXONS; BIOLOGICAL TRANSPORT; CELL SURVIVAL; GLYCOGEN SYNTHASE KINASE 3; MICE; MITOCHONDRIA; MOLECULAR IMAGING; TAU PROTEINS;

EID: 81055124828     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027686     Document Type: Article

References (46)

1. Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, et al. (2009) Axonal transport defects in neurodegenerative diseases. J Neurosci 29: 12776-12786.
2. Morfini GA, You YM, Pollema SL, Kaminska A, Liu K, et al. (2009) Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci 12: 864-871.
3. Berciano J, (2011) Peripheral neuropathies: Molecular diagnosis of Charcot-Marie-Tooth disease. Nat Rev Neurol 7: 305-306.
4. Hiruma H, Katakura T, Takahashi S, Ichikawa T, Kawakami T, (2003) Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J Neurosci 23: 8967-8977.
5. Pigino G, Morfini G, Atagi Y, Deshpande A, Yu C, et al. (2009) Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc Natl Acad Sci U S A 106: 5907-5912.
6. Shah SB, Nolan R, Davis E, Stokin GB, Niesman I, et al. (2009) Examination of potential mechanisms of amyloid-induced defects in neuronal transport. Neurobiol Dis 36: 11-25.
7. Decker H, Lo KY, Unger SM, Ferreira ST, Silverman MA, (2010) Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. J Neurosci 30: 9166-9171.
8. Vossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, et al. (2010) Tau reduction prevents Abeta-induced defects in axonal transport. Science 330: 198.
9. Ikeda K, Zhapparova O, Brodsky I, Semenova I, Tirnauer JS, et al. (2011) CK1 activates minus-end-directed transport of membrane organelles along microtubules. Mol Biol Cell 22: 1321-1329.
10. Magdesian MH, Carvalho MM, Mendes FA, Saraiva LM, Juliano MA, et al. (2008) Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling. J Biol Chem 283: 9359-9368.
11. Townsend M, Mehta T, Selkoe DJ, (2007) Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem 282: 33305-33312.
12. Hoshi M, Sato M, Matsumoto S, Noguchi A, Yasutake K, et al. (2003) Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc Natl Acad Sci U S A 100: 6370-6375.
13. De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, et al. (2008) Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. Neurobiol Aging 29: 1334-1347.
14. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST, (2002) Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 21: 281-293.
15. Cuchillo-Ibanez I, Seereeram A, Byers HL, Leung KY, Ward MA, et al. (2008) Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J 22: 3186-3195.
16. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, et al. (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol 143: 777-794.
17. Mandelkow EM, Thies E, Trinczek B, Biernat J, Mandelkow E, (2004) MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J Cell Biol 167: 99-110.
18. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, et al. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20: 27-39.
19. Dominguez I, Itoh K, Sokol SY, (1995) Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proc Natl Acad Sci U S A 92: 8498-8502.
20. De Vos KJ, Sheetz MP, (2007) Visualization and quantification of mitochondrial dynamics in living animal cells. Methods Cell Biol 80: 627-682.
21. Trinczek B, Biernat J, Baumann K, Mandelkow EM, Mandelkow E, (1995) Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules. Mol Biol Cell 6: 1887-1902.
22. Frederick RL, Shaw JM, (2007) Moving mitochondria: establishing distribution of an essential organelle. Traffic 8: 1668-1675.
23. Dixit R, Ross JL, Goldman YE, Holzbaur EL, (2008) Differential regulation of dynein and kinesin motor proteins by tau. Science 319: 1086-1089.
24. Jimenez-Mateos EM, Gonzalez-Billault C, Dawson HN, Vitek MP, Avila J, (2006) Role of MAP1B in axonal retrograde transport of mitochondria. Biochem J 397: 53-59.
25. Utton MA, Vandecandelaere A, Wagner U, Reynolds CH, Gibb GM, et al. (1997) Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. Biochem J 323 (Pt 3): 741-747.
26. Yuan A, Kumar A, Peterhoff C, Duff K, Nixon RA, (2008) Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice. J Neurosci 28: 1682-1687.
27. Morris RL, Hollenbeck PJ, (1995) Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons. J Cell Biol 131: 1315-1326.
28. Mackey S, Schuessler G, Goldberg DJ, Schwartz JH, (1981) Dependence of fast axonal transport on the local concentration of organelles. Biophys J 36: 455-459.
29. Hollenbeck PJ, Saxton WM, (2005) The axonal transport of mitochondria. J Cell Sci 118: 5411-5419.
30. Chang DT, Reynolds IJ, (2006) Mitochondrial trafficking and morphology in healthy and injured neurons. Prog Neurobiol 80: 241-268.
31. Anesti V, Scorrano L, (2006) The relationship between mitochondrial shape and function and the cytoskeleton. Biochim Biophys Acta 1757: 692-699.
32. MacAskill AF, Atkin TA, Kittler JT, (2010) Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses. Eur J Neurosci 32: 231-240.
33. MacAskill AF, Kittler JT, (2010) Control of mitochondrial transport and localization in neurons. Trends Cell Biol 20: 102-112.
34. Morel M, Authelet M, Dedecker R, Brion JP, (2010) Glycogen synthase kinase-3beta and the p25 activator of cyclin dependent kinase 5 increase pausing of mitochondria in neurons. Neuroscience 167: 1044-1056.
35. Seitz A, Kojima H, Oiwa K, Mandelkow EM, Song YH, et al. (2002) Single-molecule investigation of the interference between kinesin, tau and MAP2c. EMBO J 21: 4896-4905.
36. Mandelkow EM, Stamer K, Vogel R, Thies E, Mandelkow E, (2003) Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 24: 1079-1085.
37. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM, (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156: 1051-1063.
38. Gomez-Sintes R, Hernandez F, Bortolozzi A, Artigas F, Avila J, et al. (2007) Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice. EMBO J 26: 2743-2754.
39. Zhang LF, Shi L, Liu H, Meng FT, Liu YJ, et al. (2011) Increased hippocampal tau phosphorylation and axonal mitochondrial transport in a mouse model of chronic stress. Int J Neuropsychopharmacol pp. 1-12.
40. Kanaan NM, Morfini G, Pigino G, Lapointe NE, Andreadis A, et al. (2011) Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. Neurobiol Aging.
41. Mandell JW, Banker GA, (1996) A spatial gradient of tau protein phosphorylation in nascent axons. J Neurosci 16: 5727-5740.
42. Vershinin M, Carter BC, Razafsky DS, King SJ, Gross SP, (2007) Multiple-motor based transport and its regulation by Tau. Proc Natl Acad Sci U S A 104: 87-92.
43. Kanaan NM, Morfini GA, LaPointe NE, Pigino GF, Patterson KR, et al. (2011) Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases. J Neurosci 31: 9858-9868.
44. Avila J, Ulloa L, Diez-Guerra J, Diaz-Nido J, (1994) Role of phosphorylated MAPlB in neuritogenesis. Cell Biol Int 18: 309-314.
45. Diaz-Nido J, Serrano L, Mendez E, Avila J, (1988) A casein kinase II-related activity is involved in phosphorylation of microtubule-associated protein MAP-1B during neuroblastoma cell differentiation. J Cell Biol 106: 2057-2065.
46. Ulloa L, Diaz-Nido J, Avila J, (1993) Depletion of casein kinase II by antisense oligonucleotide prevents neuritogenesis in neuroblastoma cells. EMBO J 12: 1633-1640.